Skip to main content

Caprelsa Prices, Coupons, Copay Cards & Patient Assistance

Caprelsa (vandetanib) is a member of the EGFR inhibitors drug class and is commonly used for Thyroid Cancer.

Caprelsa is available as a brand name drug only, a generic version is not yet available. View generic Caprelsa availability for more details.

Caprelsa prices

Oral Tablet

100 mg Caprelsa oral tablet from $9,482.32 for 30 tablets
Quantity Per unit Price
30 $316.08 $9,482.32

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

300 mg Caprelsa oral tablet from $18,954.63 for 30 tablets
Quantity Per unit Price
30 $631.82 $18,954.63

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Get your FREE Drugs.com Discount Card

Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.

This is a drug discount program, not an insurance plan.

Caprelsa Coupons, Copay Cards and Rebates

Caprelsa offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Caprelsa Co-Pay Assistance Program

Eligible commercially insured patients may save on out-of-pocket costs over $50 up to the program maximum each calendar year.

Applies to:
Caprelsa
Number of uses:
Per prescription per calendar year

Form more information phone: 800-367-4999 or Visit website

Caprelsa Interim Access Program

Eligible commercially insured patients who are experiencing a delay in their coverage may be able to receive a short term supply of medication free of charge.

Applies to:
Caprelsa
Number of uses:
Temporary Assistance

Form more information phone: 800-367-4999 or Visit website

Patient Assistance & Copay Programs for Caprelsa

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Caprelsa Patient Assistance Program

Eligibility requirements:
  1. Must be uninsured or underinsured
  2. Not disclosed
  3. FDA-approved diagnosis
  4. The patient must also be permanently residing in the US or US territories.
  5. Prescribing Physician, Healthcare Facilities, Pharmacies and Patients must enroll into the Risk Evaluation and Mitigation Strategy (REMS) Program prior to initiating the patient on treatment with Caprelsa. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Caprelsa (vandetanib) Tablet

More information please phone: 800-367-4999 Visit website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.

See also: